Pharmaceutical Solvents Market Anticipated to Reach US$ 5.29 Bn by the end of 2030


As per Future Market Insights, Europe is expected to dominate the global pharmaceutical solvents market, accounting for 29.10% of market share in 2022. The alcohol segment is projected to grow at a CAGR of 4% over the forecast period.

Pharmaceutical_Solvents_Market

According to FMI’s analysis, the pharmaceuticals sector has witnessed 150% increase over the last decade. Future Market Insights in its market intelligence report on pharmaceutical solvents opines that the market’s success continues to witness a sharp rise with high expenditure on healthcare, new drug delivery systems and medicines.

Poised to surpass US$ 5.29 Bn by the end of 2030, the pharmaceutical solvents industry is betting on attaining a balance between pharmaceutical purity and the impact of solvent use in drugs on the users and the environment at large.

Attribute Details
Pharmaceutical solvents Market Size Value in 2021 US$ 3.58 Bn
Pharmaceutical solvents Market Size Value in 2030 US$ 5.29 Bn
Pharmaceutical solvents Market Historical CAGR (2015-2021) 4.10%
Pharmaceutical solvents Market CAGR (2022-2030) 4.40%

Key Companies Profiled

  • BASF SE
  • The Dow Chemical Company
  • ExxonMobil Corporation
  • Royal Dutch Shell PLC
  • Yip’s Chemical Holdings Limited
  • Mitsubishi Chemical Corporation
  • Eastman Chemical Company
  • Clariant AG
  • Merck KGaA
  • Procter & Gamble

Efficacious supply chains which include recycling of solvents and remanufacturing will pave way for negligible impact on environment and greater product purity.

Get Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1939

Key Takeaways of Pharmaceutical Solvents Market Study

  • Alcohol solvents will remain sought-after through 2030 with high uptake in the production of sanitizers amidst the COVID-19 crisis
  • The race for new vaccine development is creating prolific opportunities for market players in the near-term
  • Acetone, glycerin and chelating agents will capture one-third market share in 2020 with growth underpinned by high demand for  these in hygiene products and sanitizers
  • The soaring popularity of green solvents is set to improve process yields and lower operational costs of manufacturers in the pharmaceutical solvent landscape

Asia Pacific Continues to Gain Momentum

The biggest pharmaceutical companies such as Merck, Novartis, Roche and Pfizer are heavily dependent on the APIs and solvents from countries such as China and India who have a hegemony on global supply chains. By volume India secures an enviable third position in the manufacture of pharmaceuticals. Cumulatively China and India account for nearly 80% of APIs and solvents that are imported to other regions.

This has huge ramifications amidst the ongoing COVID-19 crisis as the world is looking at these regions for pharmaceuticals if the pandemic is to be contained. India on the back of un-patented generic drugs that are priced low also has a huge network of FDA approved solvent plants that supply nearly 45% of formulations to pharma companies in US.

However with wariness towards China setting in, many are now looking closely at India for API and solvent supply on the back of a desire for cost savings and better compliance with environmental regulations.

With solvents playing a nuanced role in novel drug delivery systems, major manufacturers of pharmaceutical solvents are ardently researching product developments that meet exacting pharmaceutical legislations and regulations. Towards this, deep eutectic solvent (DES) is garnering great interest as a green solvent.

Its superior properties such as non-reactivity to water, high solvency and non-inflammability makes it ideal for a large range of solutes. The raw materials used in these are also less toxic and inexpensive thus making them highly suitable for nanoparticle synthesis, drug delivery and as self-assembled drug carriers.

“High quality, strict compliance to regulatory frameworks, timely insights and reduction in drug development costs by at least 25% with the use of green solvents will bring about market acceleration faster”, says FMI analyst

Ask for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1939

Pharmaceutical Solvents Market By Category

Chemical Group:

  • Alcohol
    • Ethanol
    • Isopropanol
    • Propanol
    • Propylene Glycol
  • Amine
    • Aniline
    • Diphenylamine
    • Methylethanolamine
    • Trimethylamine
  • Ester
    • Acetyl Acetate
    • Ethyl Acetate
    • Butyl Acetate
  • Ether
    • Diethyl Ether
    • Anisole
    • Polyethylene Glycol
  • Chlorinated Solvents
    • Carbon Tetrachloride
    • Dichloromethane
  • Others (Chelating Agents, Acetone)

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

to be continued…!

About Future Market Insights

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.

Contact Information

Future Market Insights

Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware
19713
United States
Phone : 18455795705
View website

Published in

Business , News

Published on

Dec 15, 2022

Social Links